Makes blood volume analyzers for hospitals to diagnose heart failure and kidney disease.
Dec 2011Revenue $1.45M/yrExpenses $7.23M/yr
No trendCash runway ≈ 1 months from Dec 2011
Figures by year
When will Daxor be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2011, revenue was $1.45M and expenses $7.23M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2011 | $1.45M | $7.23M | −$5.79M |
| Dec 2010 | $1.58M | $7.24M | −$5.66M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.